Week 3 Flashcards
Cholinergic drugs
Parasympathetic nervous sys (PNS) by mimicking or inhibiting acetylcholine (ACH) which is located at the gaglions and PNS terminal nerve endings. Innervates cholinergic receptors in organs, tissues and glands
Cholinergic receptors
Nicotine and muscarinic
Cholinergic Agonist
Stimulate PNS direct (binds direct to cholinergic rreceptors at target tissue level mimicking acetylcholine) or indirectly (inhibit acetylcholinesterase, prolonging action of natural acetylcholine)
Cholinergic antagonist
Inhibit actions of acetylcholine -> inhibits PNS
Atropine, tolterodine tartrate, scopolamine
CNS antagonist
Large doses = drowsiness, disorientation and hallucinations
DV agonists
De HR, slows conduction through AV node, de BP = vasodilation
CV antagonist
Large doses ^ hr
Small doses de hr
Pulmonary agonist
^ bronchial constriction
^ bronchial secretions
Pulmonary system
De bronchial constrictions
De bronchial secretions
Gastrointestinal agonist
^ gastric motility and peristalsis
Relaxes sphincter muscles
GI antagonist
De gastric motility and peristalsis
Genitourinary agonist
Contracts bladder, relaxes bladder’s sphincter
Genitourinary antagonist
Relaxes bladder and ^ constriction of bladder sphincter
Ocular agonist
Constricts pupils
^ ability to accommodate
Ocular antagonist
Dilates pupils (mydriasis) De ability to accommodate
Glandular
^ salivation, perspiration, and tears
Glandular antagonist
de salivation, perspiration and tears
Skeletal muscle agonist
^neuromuscular transmission, maintain muscle strength and tone
Skeletal muscles antagonists
De muscle rigidity and de tremors
Bethanechol
Agonist med
Bethanechol - mechanisms of action
Direct acting agonist (binds to cholinergic receptors), stimulates muscarinic receptors in bladder and GI tract
^ bladder tone, relaxes bladder sphincter
^ GI smooth muscle tone and motility and relaxes GI sphincters
Bethanechol - therapeutic uses
Treats postoperative nonobstructive urinary retention and urinary retention associated with neurogenic gladder
Bethanechol - pharmacokinetics
Poorly absorbed from GI and % bound to plasma protein is unknown. Crosses BBB. Excreted in urging. 1/2 life is unknown. Onset = 30-90 mins (oral) lasts 2 hrs
Pre-admin - bethanechol
Head to toe assessment Med allergies Past med history Current meds Alcohol and drug use Herbal preparation use Patient baseline vitals Urine output (>1500 mL/d)
Contraindications - bethanechol
Asthma Bradycardia COPD Coronary artery disease GI obstruction Hyperthyroidism Hypotension Irritable bowl syndrome Parkinsonism Peptic ulcer disease Seizures Urinary tract obstruction Integrity of GI or bladder wall is unknown
Drug interactions - bethanechol
De given sympathomimentics, anticholinergics, opioids
^ given another cholinergic agonist (direct/indirect)
Use with caution with ganglionic blocking agents = severe hypotension
Adverse rxns of bethanechol
CV = in and de HR, de BP CNS = headache, dizziness and seizures GI. = cramping, diarrhea, ^ gastric acid secretion, ^ oral secretion Respiratory = ^ bronchial secretions, bronchospasms
Lacrimation, sweating, mitosis
Atropine
Antagonist med